三重阴性乳腺癌的局部区域复发:过去,现在和未来的乳腺癌
Jennifer Tran1, Arushi Thaper2, Nerea Lopetegui-Lia1
1Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, USA.
Expert review of anticancer therapy
|September 26, 2023
概括
三阴性乳腺癌 (TNBC) 的复发仍然是一个挑战. 本综述审查了先进的局部区域治疗方法和基因组洞察力,用于管理复发性TNBC,旨在改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 乳腺癌研究研究 乳腺癌研究
- 癌症治疗方法 癌症治疗方法
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有高复发率的侵袭性亚型.
- 目前的治疗策略在TNBC中为局部区域复发 (LRR) 提供了低于最佳的结果.
研究的目的:
- 审查TNBC中局部区域复发的不断变化的管理.
- 探索手术,辐射和系统治疗中复发性TNBC的进展.
- 讨论基因组分析的作用和未来的研究方向.
主要方法:
- 对回顾性和前性临床数据的文献综述.
- 分析手术技术,包括挽救乳腺保护手术 (SBCS).
- 评估放射治疗方式,如再辐射和热辐射.
- 探索瘤基因组分析和转录组分析.
主要成果:
- 在LRR预防方面取得的进展有限,在复发后的结果很差.
- 对于局部或区域性反复TNBC的最佳管理策略需要进一步调查.
- 分子标记物和瘤微环境显示出预测结果和指导治疗的前景.
结论:
- 像SBCS,再辐射和热辐射这样的先进疗法正在为TNBCLRR发展.
- 前性研究对于确定最佳的全身疗法至关重要.
- 基因组和生物标记驱动的方法代表了TNBCLRR管理的有希望的未来.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


